867063-97-6
Chemical Structure
Atiratecan
Synonym(s): TP300
- CAS No.: 867063-97-6
- Formula:C31H34N6O6
- Molecular Weight:586.64
IUPAC Name: (S)-9-ethyl-10,13-dioxo-1-pentyl-9,10,13,15-tetrahydro-1H,12H-pyrano[3'',4'':6',7']indolizino[2',1':5,6]pyrido[4,3,2-de]quinazolin-9-yl N-glycyl-N-methylglycinate
InChIKey: CWJSAEZZZABNRI-HKBQPEDESA-N
SMILES: O=C(O[C@](C(C=C12)=C(CO3)C(N1CC(C2=N4)=C5N(CCCCC)C=NC6=C5C4=CC=C6)=O)(CC)C3=O)CN(C(CN)=O)C
Biological Activity: Atiratecan (TP300) is a proagent of camptothecin analog CH0793076 (HY-107096). Atiratecan does not inhibit acetylcholinesterase (AChE) activities. Atiratecan shows antitumor activity against both breast cancer resistance protein (BCRP)-positive and -negative xenografts in mouse xenograft models[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Atiratecan | Atiratecan (TP300) is a proagent of camptothecin analog CH0793076 (HY-107096). Atiratecan does not inhibit acetylcholinesterase (AChE) activities. Atiratecan shows antitumor activity against both breast cancer resistance protein (BCRP)-positive and -negative xenografts in mouse xenograft models. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
